Schedule 13G
CAPR Schedule 13G filing by BlackRock
BlackRock reported beneficial ownership of 1.8M shares, representing 5.4% of CAPRICOR THERAPEUTICS, INC. in this filing.
FiledNov 12, 2024
Ownership dateSep 30, 2024
Reported shares1.8M
Reported ownership5.4%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
1.8M
Shared voting power
1.8M
Sole dispositive power
1.8M
Shared dispositive power
1.8M
Price context
Price dates alongside the ownership filing
Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.
Close near filing date$18.10as of Nov 12, 2024
Latest tracked price$3.99as of Aug 5, 2026
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- BlackRock
- CIK
- CIK0002012383
- Accession
- 0002012383-24-004386
- Form
- Schedule 13G
Read the filing in context